Subscribe To
RLFTF / Relief Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
Content Topics
Relief
Therapeutics
Participate
Wainwright
25th
Annual
Global
Investment
Conference
Stock
RLFTF
RLFTF News
By Accesswire
September 1, 2023
Relief Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
GENEVA, SWITZERLAND / ACCESSWIRE / September 1, 2023 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief Therapeutics), a bio more_horizontal
By Accesswire
January 5, 2022
Relief Therapeutics to Participate in Virtual Investor Conferences in January
GENEVA, SWITZERLAND / ACCESSWIRE / January 5, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF, RLFTY) (" Relief "), a biopharmaceutical co more_horizontal
By Accesswire
January 5, 2022
Relief Therapeutics to Participate in Virtual Investor Conferences in January
GENEVA, SWITZERLAND / ACCESSWIRE / January 5, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF, RLFTY) (" Relief "), a biopharmaceutical co more_horizontal
By Accesswire
January 5, 2022
Relief Therapeutics to Participate in Virtual Investor Conferences in January
GENEVA, SWITZERLAND / ACCESSWIRE / January 5, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF, RLFTY) (" Relief "), a biopharmaceutical co more_horizontal
By Accesswire
October 6, 2021
Relief Therapeutics Announces Filing of Lawsuit Against its U.S. Collaboration Partner, NeuroRx, Inc. and its CEO, Dr. Jonathan Javitt, for RLF-100(TM) (Aviptadil)
Lawsuit alleges multiple breaches of Collaboration Agreement GENEVA, SWITZERLAND / ACCESSWIRE / October 7, 2021 / RELIEF THERAPEUTICS Holding SA (SIX: more_horizontal
By Accesswire
October 6, 2021
Relief Therapeutics Announces Filing of Lawsuit Against its U.S. Collaboration Partner, NeuroRx, Inc. and its CEO, Dr. Jonathan Javitt, for RLF-100(TM) (Aviptadil)
Lawsuit alleges multiple breaches of Collaboration Agreement GENEVA, SWITZERLAND / ACCESSWIRE / October 7, 2021 / RELIEF THERAPEUTICS Holding SA (SIX: more_horizontal
By Accesswire
October 6, 2021
Relief Therapeutics Announces Filing of Lawsuit Against its U.S. Collaboration Partner, NeuroRx, Inc. and its CEO, Dr. Jonathan Javitt, for RLF-100(TM) (Aviptadil)
Lawsuit alleges multiple breaches of Collaboration Agreement GENEVA, SWITZERLAND / ACCESSWIRE / October 7, 2021 / RELIEF THERAPEUTICS Holding SA (SIX: more_horizontal